搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Neuroscience News
1 天
Psychedelic Therapy Could Benefit 5.6 Million People with Depression
Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...
Knowridge
15 小时
“Magic mushroom” therapy could treat depression, study finds
People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...
Psychology Today
3 小时
Beyond the High: Exploring Psychedelics as Therapeutic Tools
Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...
Verywell Health on MSN
2 天
The Surprising Role of Ketamine in Combatting Depression: A Pharmacist's Insight
Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...
Neuroscience News
2 天
Chronic Inflammation Linked to Depression
Emerging research suggests that chronic inflammation, rather than neurotransmitter deficiencies alone, may be a major factor ...
2 天
More than 5 million Americans would be eligible for psychedelic therapy, study finds
Acupuncture. Ketamine infusions. "Electroshock" or electroconvulsive therapy. The existing treatment options for those ...
来自MSN
23 小时
Ultrasound targets chronic pain, depression
SALT LAKE CITY, Utah. (Ivanhoe Newswire) - Chronic pain and treatment-resistant depression both impact millions of people. Both can be debilitating and both can leave people feeling hopeless, ...
PsyPost on MSN
9 天
Single-dose psilocybin therapy shows promise for veterans with treatment-resistant depression
A recent study published in the Journal of Affective Disorders suggests that a single dose of psilocybin may offer hope for U ...
Psychology Today
21 天
Can Sound Waves Treat Depression?
Ultrasound is already used for diagnosis and therapy. Recent studies have found it also to be a safe, effective, and rapid ...
12 小时
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 ...
2 天
Magnus Medical Announces CMS Approval of New Payment Rate for SAINT Treatment in 2025 ...
Magnus Medical, Inc., a pioneering therapeutic neuromodulation company transforming the treatment of neuropsychiatric ...
14 天
on MSN
Transcranial direct current stimulation at home may lead to significant reductions in ...
Around 63% of these participants had been classed with having treatment-resistant depression. Half the participants received ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈